The receiver operating characteristic (ROC) curve is widely used for diagnosing as well as for judging the discrimination ability of different statistical models. Although theories about ROC curves have been established and computation methods and computer software are available for cross-sectional design, limited research for estimating ROC curves and their summary statistics has been done for repeated measure designs, which are useful in many applications, such as biological, medical and health services research. Furthermore, there is no published statistical software available that can generate ROC curves and calculate summary statistics of the area under a ROC curve for data from a repeated measures design. Using generalized linear mixed model (GLMM), we estimate the predicted probabilities of the positivity of a disease or condition, and the estimated probability is then used as a bio-marker for constructing the ROC curve and computing the area under the curve. The area under a ROC curve is calculated using the Wilcoxon non-parametric approach by comparing the predicted probability of all discordant pairs of observations. The ROC curve is constructed by plotting a series of pairs of true positive rate (sensitivity) and false positive rate (1-specificity) calculated from varying cuts of positivity escalated by increments of 0.005 in predicted probability. The computation software is written in SAS/IML/MACRO v8 and can be executed in any computer that has a working SAS v8 system with SAS/IML/MACRO.
Introduction
Receiver operating characteristic (ROC) curves have been used as measures for the accuracy of diagnostic tests in medicine and other fields when the test results are continuous measures. ROC curves display the relationship between sensitivity (truepositive rate) and 1-specificity (false-positive rate) across all possible threshold values that define the positivity of a disease or condition. They show the full picture of trade-off between true positive rate and false positive rate at different levels of positivity. Summary measures of ROC curves, such as the area under the curve (AUC), the projected length of the ROC curve (PLC) and the area swept out of the ROC curve (ASC), can summarize the inherent capacity of a test or bio-marker for discriminating a diseased from a non-diseased subject across all possible levels of positivity into a single statistic. [1, 2] There is much literature on statistical methods for estimating ROC curves, calculating the area under a ROC curve and even comparing ROC curves (both independent and correlated) for cross sectional data. [3, 4, 5, 6] Although not able to 2 automatically test and compare ROC curves, most of the major statistical software packages, such as SAS [7] , STATA [8] and SPSS, [9] have procedures that can directly generate a single ROC curve and calculate the summary statistic of AUC under a crosssectional design.
Repeated measures design is widely used in biological, medical and health services research, but statistical methods for estimating ROC curves and their summary statistics have been lacking for such designs, especially regression model based approaches, which provide the opportunity to evaluate the impact of co-variates on the potency and accuracy of a test or bio-marker. In medical and health services research, for example, researchers often need to observe the change of patient's outcomes over time as a function of treatment, time and other covariates. These outcome measures are often in continuous format but can be dichotomized by choosing some clinically-meaningful critical value c and defining the test or bio-marker to be positive if the outcome measure is greater than c. For instance, we may need to analyze patient cholesterol level over time as a function of treatment, diet and other patient characteristics; we may need to observe patient health status measured by SF-36 [10] or SF-12 [11] over time as a function of process of care and structure of medical organizations; and we may need to study HIV patients' virologic outcome as a function of adherence to antiretroviral medication treatment and other covariates. The inherent longitudinal discriminating power of treatments and other covariates on outcomes that are measured over time can be analyzed and evaluated by appropriately calculated ROC curves that take into account the dependence of observations within a subject. Statistical computation methods and computer software for such analyses are few and in need. In this paper, using generalized linear mixed model (GLMM) and a Wilcoxon non-parametric approach, [12] we propose a model-based method for calculating ROC curves and the area under a ROC curve for repeated measures design. A statistical software program, written in SAS/ Macro/IML is specifically designed and created to implement the proposed algorithm and carry out the computations. With this software, one will be able to fit ROC curves and calculate the area under a ROC curve for data from repeated measure designs, which currently no software on the market can handle.
ROC curve for cross-sectional data
A ROC curve is a plot of sensitivity versus 1-specificity, where the sensitivity is defined as the probability that a test result is positive given the subject is truly diseased and the specificity is defined as the probability that the test result is negative given the subject is truly non-diseased. Let y ) , ( ∞ −∞ ∈ denote the result of a test or bio-marker with a continuous outcome, D be an indicator of diseased/positive (
) status of a subject, c be a threshold that any test result c y ≥ is considered to be diseased/positive, and ) 1 , 0 ( ∈ t be the false positive rate (1-specificity).
be the cumulative distribution function of y for diseased and non-diseased subjects. Then 1-) (c F D and ) (c F D will be the sensitivity and specificity, respectively. Let
be the survival function of y for the two groups, we can write ROC curves in a succinct form:
, where t varies from 0 to 1 as the 3 corresponding threshold c varies from ∞ to ∞ − . [13] It has been shown that the area under a ROC curve equals the unconditional probability of correct ordering, [14] that is ) ( ) (
Regression models can evaluate the impact of covariates on the accuracy of a diagnosis test or a bio-marker. When a test or bio-marker is continuous with normal error, it can be modeled through the standard linear regression model:
is the mean of y and β are the regression coefficients is X . Very often, these continuous outcomes can be dichotomized by choosing some meaningful critical value c and defining the test result or bio-marker as positive if it is greater than the critical value of c. After this conversion, the problem is translated to model the impact of covariates on binary outcome measures, such as diseased(positive) versus non-diseased(negative). To model binary outcome measures, one can model functions of µ rather than µ itself; that is to use generalized linear model (GLM) framework. The basic form of GLM can be written as
, where η is a link function that links ) ( y E with the linear predictor β X . To evaluate the impact of covariates on ROC curves, one can either model the impact of covariates on a diagnosis test or a biomarker, directly on ROC curve or even on the summary statistics of ROC curve, such as the area under a ROC curve.
Estimating ROC Curve under Repeated Measures Design
Under repeated measures design, each patient will have multiple data points over time or under different conditions. The observations within a given patient will no longer be independent and the intra-patient correlation and variation are introduced in the analyses. Due to intra-patient variation, the impact of covariates on the accuracy of a diagnostic test or a bio-marker will consist of both fixed global effect (e.g., patient's gender) as well as individual patient random effect (e.g., change over time). For both continuous and non-continuous repeated measure outcome variables, the random effects from individual subjects can be incorporated in a model through the extension of GLM to generalized linear mixed model (GLMM), [15] in which the linear predictor consists of two parts of fixed and random effects. Let ) | (
be the conditional mean of an outcome variable i y , and let
be the link function that connects i µ with a linear predictor. Then GLMM can be written as: For binary outcome measures, which can result from converting a continuous test or bio-marker by some critical value, let ij p be the probability of being diseased/positive for the ith patient at the jth time point; and ij η be the canonical link function for the ith patient at the jth time point. We can then model the probability of being diseased/positive through GLMM: 
The estimated probability ij p ( i n j n i ,..., 1 and ,..., 1 = = ) of being diseased/positive can then serve as a bio-marker for constructing the ROC curve for longitudinally discriminating a diseased/positive from a non-diseased/negative subject. The generalized linear mixed model is fitted through the macro procedure %glimmix provided by SAS (a free copy can be obtained at: http://ftp.sas.com/techsup/download/stat/.) Let ) ( , z x t ROC denote the ROC value with false-positive rate t that is associated with the fixed effect predictors x and random effects predictors z . By definition, the area under a ROC curve φ is:
where the integration limits run from 0 to 1. The area under a ROC curve has been estimated by Wilcoxon non-parametric method [1, 14, 16] , trapezoidal rule, [1, 14] which converges to Wilcoxon non-parametric estimate if the calculation intervals are the same as the observed intervals of your data, or integration of the smooth Gaussian-based ROC curve fitted by the maximum likelihood approach when the density function of a ROC curve is closed-form. [17] To calculate the area under the curve φ based on predicted probabilities from repeated measure models, we propose to use the Wilcoxon nonparametric method to compare the magnitude of the predicted probabilities of each discordant pair. The reason that we choose the Wilcoxon approach is because under the GLMM framework, there is no simple closed-form solution of the ROC curve and the Wilcoxon non-parametric approach yields ROC estimates with a better precision than the trapezoidal rule. Since each subject now has multiple observations and the outcome values could vary from time to time for a given subject (i.e., could be diseased at one time and non-diseased at another time), the subject cohort can not be simply classified as 5 diseased and non-diseased subject groups. The classification rule needs to be modified and based on the observations rather than individual subject itself. Let 
The area under a ROC curve φ is estimated as:
To generate the actual ROC curve, a series of pairs of sensitivity and 1-specificity based on the predictions from generalized linear mixed models are calculated. In order to have sufficient estimated points of sensitivity and specificity that can generate a smooth curve, we use an increment of 0.005 in predicted probability in defining positivity. Therefore, 200 pairs of sensitivity and 1-specificity will be calculated to create the ROC curve. Let For repeated measure data, if one still uses the traditional cross-sectional approach to fit ROC curves, the intra-patient correlation will be ignored in the calculation. Therefore, the parameter estimates of models will be different than that from a repeated 6 measure model with the same data and the standard errors of parameter estimates will be under-estimated. Consequently, an over aggressive conclusion will likely be made regarding the statistical significance of the parameter estimates. This inappropriate approach will result in a different ROC curve and the statistic of area under the curve. (An example is shown in section 6.)
%glmmroc Software, its Syntax and Parameters
To implement the algorithm for estimating a ROC curve and calculating its AUC summary statistics under a repeated measure design, an ad hoc statistical macro procedure (%glimmroc) has been written in SAS/IML [18] and SAS/MACRO. [19] In the macro procedure, repeated measure logistic regression is fitted by invoking the macro procedure %glimmix [20] from SAS that models binary outcomes through the SAS Proc Mixed procedure with a logit link function for binomial distribution.
%glimmix is a SAS macro for fitting generalized linear mixed models using SAS Proc Mixed and Output Delivery System (ODS). The syntax of %glimmix is similar to that of the Proc Mixed procedure. There are other options that are macro-specific, however. For example, two important ones are the error distribution and the link for function. The options error distributions include Binomial, Poisson, Normal, Gamma and Invgaussian and the default error distribution is Binomial. The options link functions encompass logit, probit, cloglog, loglog, identity, power (), log, exponential, reciprocal, nlin (non-linear link function) and user defined link functions. For each specified error distribution, there is a default link function associated with the distribution. The default link function for Binomial distribution is logit link. For a thorough description of the different options in %glimmix, see SAS System for Mixed Models in the reference list. [20] Although the syntax of %glimmix is complicated, the users of %glimmroc do not need to deal with it. All the necessary options in %glimmix are already set up internally inside the ROC software (use Binomial error with logit link function) and the users of %glimmroc only need to deal with the syntax of %glimmroc that was designed with a simple and user-friendly syntax.
Through model fitting, the predicted probability of each observation is obtained. Based on observed binary outcome variable, a total of N discordant pairs of observations are formed. For each discordant pair, ordering of the corresponding predicted probabilities are compared in relation to the observed outcome values, and the area under ROC curve is calculated by Wilcoxon non-parametric method based on these ordering results. The ROC curve is created by plotting 200 pairs of sensitivity and 1-specificity data points starting with the strictest positive criterion of 1 to the loosest positive criterion of 0.005. Figure 1 is the flowchart of the computing algorithm. The macro software has been written in a way that it is user friendly with simple syntax. There are a total of eight parameters that need to be entered (some can be left as default; for default value, you do not need to specify anything). To run the macro, one needs simply to issue: %GLIMMROC (y=,x_list=,z_list=,id=,c_s_d=,c_s_r=,weight=,dataset=);
with the parameters filled with the actual names in one's data. Each of the parameters is defined as the following:
y----------the variable name of the binary outcome x_list-----contains the list of all independent variable for the fixed effect with space in between(e.g.: age sex race) z_list-----contains the list of all independent variables for the random effects with space in between (e.g., time) ID---------the variable of patient ID which identifies observations within a patient c_s_d------specify the covariance structure of matrix D (for the random part of GLMM and the default is simple, e.g., diagonal matrix.) c_s_r------specify the covariance structure of matrix R (for the error of the model and the default is compound symmetry) weight-----weight variable (the default is unweighted) dataset----the name of the data set on which one will run the macro procedure.
To use the procedure, one needs either copy the macro procedure into his/her SAS program or use "%include" statement at the beginning of a SAS program to load the macro procedure. The outputs of the macro procedure include the ROC curve and its summary statistics of the area under the ROC curve.
Although the %glimmroc software invokes %glimmix macro to fit repeated measures logistic models, there are several other related software and procedures that also can fit repeated measures logistic models. For example, (1) the software procedure MIXOR of the Mixed-up Suite by Donald Hedeker provides estimates for a mixed-effects ordinal probit and logistic regression model (http://www.dsi-software.com/mixor.html). This procedure can be used for analysis of clustered longitudinal ordinal (and dichotomous) outcomes data. (2) NLME software (written by Jose C. Pinheiro & Douglas M. Bates) of S_Plus and R can fit mixed effects models that provides a powerful and flexible tool for the analysis of balanced and unbalanced grouped data, including repeated measures data, longitudinal studies, and nested designs (http://nlme.stat.wisc.edu/.) The NLME software comprises a set of S (S_PLUS) functions, methods, and classes for the analysis of both linear and nonlinear mixed-effects models. (3) the NLMIXED procedure of SAS/STAT can fit non-linear mixed effect models including logistic regressions [7] . (4) the xtgee procedure of STATA software uses generalized estimating equation approach and can fit general linear models and allows one to specify the within-group correlation structure for panel data.
%glimmroc uses %glimmix rather than other available software/procedures to obtain the predicted values because we want the ROC software to be built within a single software language and to fit common linear mixed models. %*********get ROC curve*************; data yy; set pred; /*if pred^=.;*/ do i=1 to 200; if mu>0.005*i then y=1; else if .z<mu<0.005*i then y=0; else y=.; output; end; run; proc sort data=yy; by i; run; %********get sensitivity and specificity*************; proc freq data=yy; tables y*obs/noprint out=pct outpct; by i; run; data sen; set pct; if y=0 and obs=0; sensi=PCT_COL; cut=0.005*i; run; data spc; set pct; if y=1 and obs=1; speci=PCT_COL; cut=0.005*i; run; data curve1; merge sen spc; by cut; _spc=100-speci; run; data curve; set curve1; sensi1=sensi/100; _spc1=_spc/100; run; proc sort data=curve; by _spc1; run; title "ROC curve"; symbol1 i=join v=star line=3 c=red; axis1 order=(0 to 1 by 0.1); axis2 order=(0 to 1 by 0.1) label=(a=90); proc gplot data=curve; plot sensi1*_spc1=1/vaxis=axis2 haxis=axis1; label sensi1='Sensitivity'; label _spc1='1-Specificity'; run; quit; %mend glimmroc;
Application--an Example
ROC curves have wide applications, ranging from signal detection in psychophysics, radiologic image readings and diagnostic tests to judge the discrimination ability of different statistical methods for predictive purposes. To increase the accuracy of data collected from each subject, to reduce the cost of collecting data from different subjects and to be able to study changes over time, repeated measures data are often collected. Through an example, this section demonstrates the input, output and the functionality of the %glimmroc software and how the procedure works with the data example. It also demonstrates the possible mistakes that one will make if they ignore the repeated measure design and use a traditional ROC calculation procedure.
The data was obtained by measuring HIV patient adherence to antiretroviral medications. Adherence to antiretroviral medication is critical in suppressing viral replication and preventing drug-resistant strains. Due to the complexity in measuring adherence behavior, different measurement tools and mechanisms have been developed with different inherent strengths and weaknesses. Medication Event Monitoring system (MEMS) [21] and Pill Count (PC) are two popular measuring methods. MEMS is a pill bottle cap containing a microchip that records each instance of bottle opening. PC adherence is calculated by counting the number of pills remaining in a patient's bottle or bottles at a visit. Studies have shown that MEMS adherence is more objective but expensive to implement, and that PC, though not costly, likely over-estimates a patient's true adherence level due to reasons such as pill dumping. To evaluate how well PC can measure adherence over time (using MEMS as a gold standard for adherence), MEMS and PC data along with the patient's baseline lowest CD4 count (a measure of sickness level) were collected for 140 HIV+ patients at every 4-week period (a wave) for 48 weeks. For each of the 12 waves, a patient's adherence behavior was dichotomized as either "adherent" if the patient took at least 85% of the prescribed doses or "nonadherent" if the patient took less than 85% prescribed doses for that wave. There are a total of 1226 observations in the data set and the 140 HIV + patients had an average of 8.76 repeated measurements. Due to the complexity in measuring medication adherence (especially for HIV medication regimens), missing data is quite common. Among the 1226 data points, 19.5% (293 data points) of the PC data are actually missing.
The data set is named ANAL and the variables are At beginning of the SAS program, a statement "%include 'c:\tt\roc\glimmroc'; " is issued to invoke the macro procedure to avoid copying the whole code as part of the program (assume that the macro is saved in the subdirectory c:\tt\roc.) Before running the macro procedure, we tested, using AIC the penalized likelihood as a criterion, that a variance component (vc) covariance structure for matrix G (for the random coefficient part, 2 parameters) and a heterogeneous compound symmetry (csh) covariance structure for matrix R (the error part, 13 parameters) produce a better fit. [22] The covariance matrix vc and csh correctly specify the intra-subject and inter-subject correlations of the data, therefore ensure the validity of the estimations of the regression parameters and their standard errors. To estimate the ROC curve and calculate the area under the curve for evaluating the longitudinal predicting power of PC on adherence, the following statement is issued after the data step, where the data set ANAL is constructed containing all the necessary variables available: %glimmroc(y=bi_mems, x_list=lowestcd pc wave, z_list=wave, ID=id, c_s_g=vc, c_s_r=csh, dataset=anal); run;
In the above macro call, y=bi_mems is the dependent variable, x_list=lowestcd pc wave is the fixed effect, and z_list=wave is the random effect. The parameters c_s_g=vc and c_s_r=csh are the covariance structure of the random effect and the random error. vc (variance component) is the structure specification of the matrix G and csh (Heterogeneous compound symmetry) is the structure specification of matrix R (see notations of G and R in Section 3, pages 3-4). These covariance structures are the options of SAS Proc Mixed procedure that is invoked by the macro %glimmix, and in turn, which is invoked by this ROC software. There are total of 31 different covariance structures to choose from in the Proc Mixed procedure (listed on page 2138 in Table 41.3 and Table  41 .4 of SAS/STAT manual.) Although a variety of structures are available, most applications fit well with either Variance Component, Compound Symmetry (CS), Heterogeneous CS, Autoregressive (1) (AR (1)) or Unstructured covariance stricture (UN). One can use the penalized likelihood AIC to determine optimal covariance structures for one's data before running the ROC software. These different covariance structures are part of the options of the REAPEATED and the RANDOM statements in the Proc Mixed procedure. The REPEATED statement specifies the R matrix and defines the blocks of observations (each block belongs to one subject) through its subject option. If no REPEATED statement is specified, R is assumed to be equal to I 2 σ and the intrasubject correlation will be totally ignored. The RANDOM statement is to define the random effects (the subject level variation) and the structure of matrix G. A detailed description of the functionality and options of Proc Mixed can be found in chapter 41, SAS/STAT user manual. [7] Since the analysis is unweighted in this example, the 'weight' option is left out. The outputs of the macro procedure include ROC curve ( Figure 2 ) and its summary statistics of the area under the curve: 15 Area under the ROC curve = 0.76477 If one overlooks the underlying data structure of repeated measure design of this data and fits a ROC curve and estimates the area under the curve with a traditional crosssectional approach, they will get different results. For the exactly same data, using SAS Proc Logistic for cross-sectional analysis and treating the 1226 observations as independent from 1226 different patients, we got a different ROC curve. The estimated area under the curve with the cross-sectional approach is only equal to only 0.735, which is smaller than the area under the ROC curve with the repeated measures analysis approach in Figure 2 . Thus, if one neglects the nature of repeated measures of this data structure and uses the traditional across-sectional approach, they will underestimate the area under the ROC curve by 4.1% [(0.76477-0.735)/0.735]. In other words, one would underestimate the discriminating power of pill count for predicting adherence to antiretroviral medication by 4.1% from this data if they use the traditional cross-sectional analysis. For data from other studies, this difference could be even bigger.
